Orimo Kenta, Matsukawa Takashi, Mitsutake Akihiko, Cho Takusei, Naruse Hiroya, Sakiyama Yoshio, Sumi Kensho, Uchio Naohiro, Satake Akane, Takiyama Yoshihisa, Matsushita Takuya, Omae Yosuke, Kawai Yosuke, Tokunaga Katsushi, Mitsui Jun, Ishiura Hiroyuki, Tsuji Shoji, Toda Tatsushi
Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Department of Neurology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
J Neurol Sci. 2025 May 15;472:123486. doi: 10.1016/j.jns.2025.123486. Epub 2025 Apr 3.
Biallelic loss-of-function variants in CLCN2 lead to CLCN2-related leukoencephalopathy (CC2L), also called leukoencephalopathy with ataxia (LKPAT). CC2L is characterized clinically by a spectrum of clinical presentations including childhood- to adult-onset mild ataxia, spasticity, cognitive decline, and vision loss as well as typical MRI findings of symmetrical high signal intensities on the DWIs/T2WIs of the middle cerebellar peduncles (MCPs). We searched for pathogenic variants of CLCN2 in a case series of undiagnosed leukoencephalopathy accompanied by MCP signs, which led to the identification of four Japanese patients with CC2L. All the patients carried at least one allele of c.61dupC (p.Leu21Profs27) in CLCN2, including compound heterozygosity with either the novel pathogenic variant c.983 + 2 T > A or the previously reported pathogenic variant c.1828C > T (p.Arg610). Of note, all the four previously reported cases from Japan also harbored c.61dupC, and no reports of this variant have been documented from outside Japan. The allele frequency of c.61dupC in the Japanese population is 0.002152, raising the possibility of a relatively high prevalence of CC2L in Japan. Patients in this study developed symptoms after the age of 30, and demonstrated neurological signs including cerebellar ataxia, pyramidal signs, and mild cognitive impairment, consistent with previous reports. One male patient had two children, supporting preserved fertility, and another patient had calcifications in the cerebral and cerebellar surfaces. These findings provide valuable insights into the broader clinical and genetic spectra of CC2L in the Japanese population, and emphasize the importance of considering this disease in the differential diagnoses of leukoencephalopathy with MCP signs.
CLCN2基因的双等位基因功能丧失变异会导致CLCN2相关白质脑病(CC2L),也称为伴共济失调的白质脑病(LKPAT)。CC2L的临床特征是一系列临床表现,包括儿童期至成人期的轻度共济失调、痉挛、认知衰退和视力丧失,以及在小脑中间脚(MCP)的扩散加权成像/ T2加权成像上出现对称高信号强度的典型磁共振成像表现。我们在一系列伴有MCP体征的未确诊白质脑病病例中寻找CLCN2的致病变异,从而鉴定出4例日本CC2L患者。所有患者在CLCN2基因中至少携带一个c.61dupC(p.Leu21Profs27)等位基因,包括与新的致病变异c.983 + 2 T > A或先前报道的致病变异c.1828C > T(p.Arg610)的复合杂合性。值得注意的是,之前报道的所有4例日本病例也都携带c.61dupC,日本以外地区尚无该变异的报道。c.61dupC在日本人群中的等位基因频率为0.002152,这增加了CC2L在日本相对高发的可能性。本研究中的患者在30岁以后出现症状,并表现出包括小脑共济失调、锥体束征和轻度认知障碍在内的神经体征,与先前报道一致。一名男性患者育有两个孩子,表明生育能力未受影响,另一名患者在大脑和小脑表面有钙化。这些发现为日本人群中CC2L更广泛的临床和遗传谱提供了有价值的见解,并强调了在伴有MCP体征的白质脑病鉴别诊断中考虑这种疾病的重要性。